Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP78790.RAivRXARHLWvbuuh3bnLJfn072n5Ry9NCAaEYniklozxE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP78790.RAivRXARHLWvbuuh3bnLJfn072n5Ry9NCAaEYniklozxE130_assertion type Assertion NP78790.RAivRXARHLWvbuuh3bnLJfn072n5Ry9NCAaEYniklozxE130_head.
- NP78790.RAivRXARHLWvbuuh3bnLJfn072n5Ry9NCAaEYniklozxE130_assertion description "[B2 bradykinin receptor (B2BKR) polymorphism and change in left ventricular mass in response to antihypertensive treatment: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA) trial.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP78790.RAivRXARHLWvbuuh3bnLJfn072n5Ry9NCAaEYniklozxE130_provenance.
- NP78790.RAivRXARHLWvbuuh3bnLJfn072n5Ry9NCAaEYniklozxE130_assertion evidence source_evidence_literature NP78790.RAivRXARHLWvbuuh3bnLJfn072n5Ry9NCAaEYniklozxE130_provenance.
- NP78790.RAivRXARHLWvbuuh3bnLJfn072n5Ry9NCAaEYniklozxE130_assertion SIO_000772 12640257 NP78790.RAivRXARHLWvbuuh3bnLJfn072n5Ry9NCAaEYniklozxE130_provenance.
- NP78790.RAivRXARHLWvbuuh3bnLJfn072n5Ry9NCAaEYniklozxE130_assertion wasDerivedFrom gad-20150221 NP78790.RAivRXARHLWvbuuh3bnLJfn072n5Ry9NCAaEYniklozxE130_provenance.
- NP78790.RAivRXARHLWvbuuh3bnLJfn072n5Ry9NCAaEYniklozxE130_assertion wasGeneratedBy ECO_0000203 NP78790.RAivRXARHLWvbuuh3bnLJfn072n5Ry9NCAaEYniklozxE130_provenance.